Oryzon Genomics SA (ORYZF)
3.098
0.00 (0.00%)
USD |
OTCM |
Nov 17, 16:00
Oryzon Genomics Price : 3.098 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Nov 16, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Nov 13, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Nov 12, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Nov 11, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Nov 10, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Nov 09, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Nov 06, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Nov 05, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Nov 04, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Nov 03, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Nov 02, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Oct 30, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Oct 29, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Oct 28, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Oct 27, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Oct 26, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Oct 23, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Oct 22, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Oct 21, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Oct 20, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Oct 19, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Oct 16, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Oct 15, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Oct 14, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Pharma Mar SA | 72.54 |
| Grifols SA | 8.60 |
| ACADIA Pharmaceuticals, Inc. | 18.42 |
| Alkermes Plc | 46.51 |
| Alnylam Pharmaceuticals, Inc. | 156.00 |
Price Related Metrics
| PEG Ratio | -1.250 |
| Price to Book Value | 2.015 |
| Earnings Yield | -1.96% |
| Market Cap | 240.11M |
| PEGY Ratio | -1.250 |